August 29, 2018
South Korea’s Celltrion launched a biosimilar version of the cancer drug Herceptin (trastuzumab) in Japan on August 28, which was codeveloped with Nippon Kayaku and approved for an indication of gastric cancer back in March. Trastuzumab BS for IV Infusion...read more